Free Newsletter
Obesity research points to new therapeutic target
Obese people have large concentrations of bacteria called Firmicutes in their gut, which are very efficient when it comes to extracting calories from food. And researchers say that the bacteria helps explain why some people are quick to gain weight and why it is harder for the obese to lose weight. By transferring Firmicutes from the guts of fat mice to lean mice, researchers reported, the lean mice gained weight. That suggests that finding ways to control Firmicutes may offer a new pathway to treating or preventing obesity. Their work is outlined in the current issue of Nature.
- read The Washington Post report on the obesity research
Related Articles:
Molecular research points to new obesity therapy. Report
Scripps researchers find anti-obesity vaccine. Report
Solvay earns $25M as obesity drug advances. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: